Rationale and Design for the Blood Pressure Intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial
Open Access
- 1 June 2007
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 99 (12) , S44-S55
- https://doi.org/10.1016/j.amjcard.2007.03.005
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 ReportJAMA, 2003
- Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profilesJournal Of Hypertension, 2003
- Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational studyBMJ, 2000
- Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic HypertensionNew England Journal of Medicine, 1999
- Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39BMJ, 1998
- Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38BMJ, 1998
- Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trialThe Lancet, 1998
- Effect of Diuretic-Based Antihypertensive Treatment on Cardiovascular Disease Risk in Older Diabetic Patients With Isolated Systolic HypertensionPublished by American Medical Association (AMA) ,1996
- Appropriate Blood Pressure Control in NIDDM (ABCD) TrialDiabetologia, 1996
- Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention TrialDiabetes Care, 1993